Articles written specifically for the GLP or the articles that are reposted from other sources (sometimes in modified form) with permission list the source as Genetic Literacy Project. Excerpted articles list the original media outlet as the source. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair Use policy for posting excerpts and using images is explained here.

European court appears poised to rule that gene edited crops should not be regulated as GMOs

Reuters | 
Gene editing in agriculture takes centre stage [July 25th] when Europe’s highest court rules in a case that could determine ...
Post GMO era: EU faces defining moment in regulating gene editing

Post GMO era: EU faces defining moment in regulating gene editing

Reuters | 
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Last month, a non-browning ...

Gene therapy to restore hearing in deaf works in mice; humans next

Reuters | 
Gene therapy for deafness is moving closer to reality, with new research showing the technique for fixing faulty DNA can ...

Ongoing lack of MERS vaccine inexcusable as virus spreads in South Korea

Reuters | 
Three years after the mysterious MERS virus first emerged in humans, scientists and drugmakers say there is no excuse for ...

China’s spending on genetics research making huge advances in biotech

Reuters | 
Years of pouring money into its laboratories, wooing scientists home from overseas and urging researchers to publish and patent is ...

First ever gene therapy drug comes at high price

Reuters | 
The Western world's first gene therapy drug is set to go on sale in Germany with a 1.1 million euro ...
d d c z

Are we entering the age of $1 million medicine?

Reuters | 
More than a quarter of the new medicines approved in the United States last year were designated for rare or ...

European regulators back western world’s first gene therapy drug

AlertNet | 
European regulators have recommended approval of the Western world's first gene therapy drug -- after rejecting it on three previous ...

Going hostile with $2.6 billion Human Genome offer

Yahoo News | 
GlaxoSmithKline will take its $2.6 billion bid for long-time partner Human Genome Sciences direct to shareholders this week, after its ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists